报告重组干扰素静脉滴注治疗新生儿呼吸道合胞病毒(RSV)肺炎13例,对照组11例。结果表明:治疗组在临床症状及体征消失时间、平均住院日数均明显短于对照组(P<0.05),临床应用具有剂量小、准确、疗程短之优点。 The report of intravenous recombinant interferon treatment of neonatal respiratory syncytial virus (RSV) pneumonia in 13 cases, control group of 11 cases. The results showed that the clinical symptoms and signs of the disappearance of the time, the average length of stay in the treatment group were significantly shorter than the control group (P <0.05), the clinical application of a small dose, accurate, short course of the advantages.